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Objective – To report a very rare case of syringocystadenoma papil-
liferum, describing its clinical presentation, histopathological appear-
ance and surgical management. Case report – An 11-year-old girl 
presented with a partially lobulated linear plaque on her right lower 
back present since birth, which was clinically diagnosed at first as lin-
ear epidermal nevus. The tumor was surgically removed. The histopa-
thology confirmed the diagnosis of syringocystadenoma papilliferum. 
Conclusion – Syringocystadenoma papilliferum is a benign adnexal 
tumor that occurs most often in the head and neck. The tumor has 
characteristic histological features, and varied and non-distinct clinical 
findings. Although extremely rare, this lesion should be considered in 
the differential diagnosis of skin tumors in children.
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Introduction
Syringocystadenoma papilliferum (SCAP) 
is a very rare benign hamartomaous skin tu-
mor. Its exact histogenesis remains unclear, 
and possible apocrine, eccrine or apoeccrine 
origin has been broadly debated (1). Tumors 
are usually seen at birth or appear during 
childhood and tend to proliferate around pu-
berty (2). SCAP may occur de novo or within 
a nevus sebaceous. The majority of patients 
present with a solitary lesion in the head and 
neck region (2). The localization over abdo-
men is rare, and only seven cases have been 
published in the literature. We report an un-
usual case of SCAP presenting on the back. 
Case report
An 11-year-old girl presented with a discrete 
pink-colored superficial, occasionally pruritic 
lesion on the right lower back. The lesion 
had been present since birth, and no sig-
nificant change in size or general appearance 
was noted in the following years. A physical 
examination revealed a solitary, 1,5x1 cm in 
size hairless plaque, with partially lobular 
structure. The clinical suspicion was a linear 
epidermal nevus. There were no associated 
systemic symptoms. The routine hemato-
logical and biochemical tests were normal. 
The patient was referred to the pediatric 
surgeon for complete excision. Histopatho-
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logic examination (Fig. 1) demonstrated 
cystic invagination of epidermis with papil-
lary proliferation. Papillae were mostly lined 
by multilayer squamous epithelium, with 
inner row of small myoepithelial cells and 
columnar cells in the outer layer. Glandular 
formations were interspersed in epithelium. 
The fibrovascular core of the papillae showed 
plasmacellular inflammatory infiltrate. The 
underlying deep dermis showed two cystic 
enlarged channels. Slightly hyperplastic, hy-
perkeratotic and parakeratotic epithelium 
was located peripherally. These findings were 
consistent with the diagnosis of SCAP. The 
postoperative period was uneventful. At one-
year follow-up, the girl is doing well with no 
evidence of local recurrence.
Discussion
SCAP is an uncommon benign hamartoma-
tous adnexal tumor. The histogenesis remains 
unclear, and the results of immunohisto-
chemistry and electron microscopy have been 
conflicting (4). It was postulated that SCAP 
arises from a pluripotent cells with the po-
tential to exhibit either apocrine or eccrine 
differentiation, but there is an increasing evi-
dence for an apocrine origin (1). Three clini-
cal types have been described. It may present 
as a solitary nodule (solitary nodular form), 
a nodular hairless plaque (plaque type), or 
as a linear group of brownish or erythema-
tous papules or nodules (linear type) (3). The 
tumor varies in size from 5 to 160 mm (5). 
The surface can be smooth, flat, papilloma-
tous, or verrucous. Most of the patients pres-
ent with solitary lesions. Multiple lesions are 
usually associated with naevus sebaceous (3, 
5). SCAP is also associated with linear nae-
vus verrucosus, apocrine poroma, apocrine 
hidrocystoma, tubulopapillary hidradenoma, 
hidradenoma papilliferum, papillary eccrine 
adenoma, apocrine acrosyringeal keratosis, 
Fig. 1  Syringocystadenoma papilliferum:  (A) invaginations from the overlying epidermis (B) fulfilled with 
papillae, covered with a luminar layer of tall columnar cells and the inner layer of small myoepithelial cells with 
hyperchromatic nuclei.   
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poroma folliculare, linear naevus verrucosa, 
atypical fibroxanthoma, clear cell syringoma, 
basal cell epithelioma, sebaceous epithelio-
ma, trichoepithelioma, verruca vulgaris, and 
naevus comedonicus. The most common as-
sociated lesion is nevus sebaceous (31,7%), 
followed by basal cell epithelioma (10,3%), 
sebaceous epithelioma (3,2%), apocrine 
hidrocystoma (3,2%), trichoepithelioma 
(1,6%), and eccrine spiradenoma (0,8%) (6). 
In contrast to a widely variable clinical ap-
pearance, the histopathology is uniform and 
confirmatory. SCAP is characterized by cystic 
invaginations extending downwards from the 
epidermis. The upper regions of the cystic in-
vaginations are commonly lined by keratin-
izing squamous epithelial cells. The lower 
regions, which contain numerous papillary 
projections, are lined by glandular epitheli-
um consisting of two rows of cells: a luminar 
layer of high columnar cells frequently dem-
onstrating “decapitation” secretion (charac-
teristic of the secretory cells of the apocrine 
sweat glands), and a basal layer of small cu-
boidal cells with strongly basophilic nuclei. 
The connective tissue stroma within the 
papillary projections is marked by rich infil-
tration of inflammatory cells; most notably 
there is a large number of plasma cells. 
Almost half of the tumors are present at 
birth or appear during infancy. The lesion 
usually increases in size at puberty, becoming 
papillomatous and crusted. The great major-
ity of SCAP occur in the head and neck area. 
Mammino et al. reviewed 145 cases of SCAP 
and found 108 cases (75%) on the head and 
neck, 29 cases (20%) on the trunk, and 8 
cases (5%) on the extremities (2). However, 
over last two decades there are increasing re-
ports of SCAP occurring in unusual locations 
outside the head and neck region (7). 
Malignant transformation may occur. 
Basal cell carcinoma development has been 
reported in up to 10% of SCAP, in the major-
ity of them with coexistent nevus sebaceous. 
Allelic loss at 9q22 is consistent with the clin-
ical observation of transition of SCAP to bas-
al cell carcinoma. Squamous cell carcinoma, 
verrucous carcinoma and ductal carcinoma 
arising from SCAP have been published (3). 
Syringocistadenocarcinoma papilliferum is a 
malignant counterpart of SCAP (8, 9).
The treatment of choice for SCAP is 
complete surgical excision. Carbon dioxide 
laser can be useful for lesions on anatomic 
sites not suitable for surgery (9). To date, 
there are few reported cases of SCAP of aris-
ing on the abdomen (7, 10-17). Our patient 
had an extremely rare location of the plaque 
type. Her tumor was present since birth and, 
unusual for this type of the tumor, did not 
change over time. There was no association 
with other benign adnexal lesion. Based on 
the appearance of the lesion and the long his-
tory, SCAP was not clinically suspected in 
our case. We performed a complete excision 
with detailed histologic examination. This 
case emphasizes that SCAP should be consid-
ered in the differential diagnosis of childhood 
adnexal tumors. 
Conclusion
Solitary skin lesions in unusual locations in 
children have a wide array of differential di-
agnoses, including SCAP. The treatment of 
choice is a local excision with confirmatory 
histopathology. 
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